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ABSTRACT 
Mitochondrial DNA (mtDNA) mutator mice are proposed to express premature 
aging phenotypes including kyphosis and hair loss (alopecia) due to their carrying a 
nuclear genome-encoded mtDNA polymerase with a defective proofreading function, 
which causes accelerated accumulation of random mutations in mtDNA, resulting in 
expression of respiration defects. On the contrary, trans-mitochondrial mito-miceΔ 
carrying mtDNA with a large-scale deletion mutation (ΔmtDNA) also express respiration 
defects, but not express premature aging phenotypes. I resolved this discrepancy by 
generating mtDNA mutator mice sharing the same C57BL/6J (B6J) nuclear background 
with that of mito-miceΔ. Expression patterns of premature aging phenotypes are very 
close, when I compared between homozygous mtDNA mutator mice carrying a B6J 
nuclear background and selected mito-miceΔ only carrying predominant amounts of 
ΔmtDNA, in their expression of significant respiration defects, kyphosis, and a short 
lifespan, but not the alopecia. Therefore, the apparent discrepancy in the presence and 
absence of premature aging phenotypes in mtDNA mutator mice and mito-miceΔ, 
respectively, is partly the result of differences in the nuclear background of mtDNA 
mutator mice and of the broad range of ΔmtDNA proportions of mito-miceΔ used in 
previous studies. Then I focused on the issue of whether premature aging phenotypes 
expressed in mtDNA mutator mice are associated with aging or mitochondrial diseases 
or both by using aged mice and mito-miceΔ as controls of aging and mitochondrial 
diseases, respectively. I provided convincing evidence that all three mice I used expressed 
osteoporosis and muscle atrophy, which are supposed to be age-associated phenotypes. 
However, precise investigation of osteoporosis and muscle atrophy revealed that 
expression spectra of these phenotypes in mtDNA mutator mice are very close to those 
of mito-miceΔ, but are different from those of aged mice and elderly human subjects. I 
also provided direct evidence that mtDNA abnormalities in homozygous mtDNA mutator 
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mice are responsible for respiration defects by demonstrating the co-transfer of mtDNA 
and respiration defects from mtDNA mutator mice into mtDNA-less (ρ0) mouse cells. 
Moreover, heterozygous mtDNA mutator mice had a normal lifespan, but frequently 
developed B-cell lymphoma, suggesting that the mtDNA abnormalities in heterozygous 
mutator mice are not sufficient to induce a short lifespan and aging phenotypes, but are 
able to contribute to the B-cell lymphoma development during their prolonged lifespan. 
  
3 
 
INTRODUCTION 
It has been hypothesized that pathogenic mtDNA mutations that induce 
significant mitochondrial respiration defects cause mitochondrial diseases [1, 2] and 
could also be involved in aging and age-associated disorders including tumor 
development [1–5]. This hypothesis is partly supported by studies in mtDNA mutator 
mice [6-8]: they possess a nuclear genome-encoded mtDNA polymerase with a defective 
proofreading function that leads to enhanced accumulation of random mutations in 
mtDNA with age, and the subsequent phenotypic expression of age-associated respiration 
defects and premature aging phenotypes, but not tumor development. 
       On the contrary, previous studies [9, 10] showed that trans-mitochondrial mito-
miceΔ carrying mtDNA with a large-scale deletion mutation (ΔmtDNA) expressed age-
associated respiration defects, but did not express the premature aging phenotypes. 
Similar results were obtained in other trans-mitochondrial mito-miceCOIM, which have 
an mtDNA point mutation in the COI gene and trans-mitochondrial mito-miceND6M, 
which have an mtDNA point mutation in the ND6 gene that is derived from Lewis lung 
carcinomas, and confers respiration defects and overproduction of reactive oxygen 
species (ROS) [11-13]. Mito-miceND6M did not express premature aging phenotypes, but 
were prone to B-cell lymphoma development [14]. Moreover, it was revealed that age-
associated respiration defects found in human fibroblasts are not caused by mtDNA 
mutations [15, 16] but by nuclear-recessive mutations [16]. Thus, it appears to be 
discrepant that premature aging phenotypes are exclusively observed in mtDNA mutator 
mice [6-8], but not in trans-mitochondrial mito-mice [9-11, 14], even though they all 
express mitochondrial respiration defects caused by mutated mtDNA. 
This discrepancy may partly be the result of differences in the nuclear genetic 
background between mtDNA mutator mice and trans-mitochondrial mito-mice. It is also 
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possible that the premature aging phenotypes found exclusively in mtDNA mutator mice 
are not caused by mutations in mtDNA, because inter-mitochondrial interaction and the 
resultant genetic complementation in mammalian mitochondria may prevent random 
mutations in mtDNA being expressed as respiration defects [10, 17, 18].  
To clarify these issues, first I generated mtDNA mutator mice with the same 
C57BL/6J (B6J) nuclear genetic background as that of mito-miceΔ, and examined 
whether they still expressed respiration defects and premature aging phenotypes. Then I 
addressed the question that whether mtDNA mutator mice correspond to a model of aging 
or mitochondrial diseases by using aged mice and mito-miceΔ as positive controls for 
aging and mitochondrial diseases, respectively, and investigated precisely 
musculoskeletal disorders, including osteoporosis and muscle atrophy, which have been 
reported in elderly human subjects [19] and mtDNA mutator mice [6, 7]. 
In addition, I transferred mtDNA from mtDNA mutator mice into mtDNA-less 
(0) mouse cells and isolated trans-mitochondrial cybrids possessing mtDNA transferred 
from the mtDNA mutator mice, but not possessing defective mtDNA polymerase from 
the mtDNA mutator mice, and examined whether the resultant trans-mitochondrial 
cybrids expressed the expected respiration defects. 
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MATERIALS & METHODS 
Mice 
Inbred B6J mice generated by sibling mating more than 40 times were obtained 
from CLEA Japan. Mito-miceΔ were generated in previous report [9]. Homo- and 
heterozygous mtDNA mutator mice were generated based on the procedures reported 
previously [6, 7] with a few modifications. I converted nucleotides 4460-4465 of the Polg 
sequence from GACCGA to GCGCGC to introduce a D257A mutation in Polg and create 
BssHII site for genotyping by PCR-RFLP method. Animal experiments were performed 
in accordance with protocols approved by the Experimental Animal Committee of the 
University of Tsukuba, Japan.  
Mouse Cell Lines and Cell Culture 
Mouse B82 cells are fibrosarcomas derived from the L929 fibroblast cell line 
(C3H/An mouse strain) [20], and ρ0 B82 cells without mtDNA were obtained in a 
previous study [9]. Trans-mitochondrial cybrids were isolated by the fusion of the 
platelets from mtDNA mutator mice with ρ0 B82 cells by polyethylene glycol and 
subsequent selection that allows exclusive growth of the trans-mitochondrial cybrids (see 
Table 1). For isolation of immortalized 3T3 cells, MEFs in a 6-cm culture dish at a density 
of 3×105 cells per dish were cultured using the 3T3 protocol [21, 22]. Briefly, 3 days after 
the cells had been plated at 3×105 cells per dish, I trypsinized them, counted the total cell 
numbers, and then replated 3×105 cells into 6-cm dishes. These processes were repeated 
until immortalized cells appeared. The mouse cells and cell lines were grown in DMEM 
(Sigma) containing 10% fetal calf serum, uridine (50 ng/ml), and pyruvate (0.1 mg/ml). 
Analysis of COX activity 
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Histochemical analyses for COX and SDH activity were carried out based on the 
procedures as described previously [23] using cryosections (10 µm thick) of cardiac 
muscles, renal tissues, quadriceps muscles, and coverslips with growing 3T3 cells, 
osteoclasts, and osteoblasts. 
Measurement of O2 Consumption Rates in Mouse Cell Lines 
The rate of oxygen consumption was measured by trypsinizing cells, incubating 
the suspension in PBS, and recording oxygen consumption in a 2.0-ml polarographic cell 
at 37°C with a Clark-type oxygen electrode (Yellow Springs Instruments). 
Analysis of mtDNA mutations 
Total DNA was extracted from cells and tissues, and somatic mtDNA mutation 
load was determined by PCR, cloning, and sequencing, using primers that speciﬁcally 
ampliﬁed a part of COX1 gene (nucleotide pair 6,006–6,522) of mouse mtDNA. PCR 
products were subcloned into the pTA2 T-vector using by TArget Clone Plus Kit 
(TOYOBO, Osaka, Japan). Fifty plasmids were randomly selected from the each sample, 
were isolated using DirectPrep 96 MiniPrep Kit (Qiagen, Valencia, CA) and sequenced 
with M13 forward and reverse primers using BigDye Terminator Kit (Life Technologies, 
Grand Island, NY) on an Applied Biosystems 3130xl Genetic Analyzer. Sequences were 
assembled and edited in GENETYX ver10 (GENETYX Corporation, Tokyo, Japan). 
Southern-blot analysis 
Total DNA (5 µg and 3 µg) extracted from cells and tissues was digested with 
the restriction endonuclease XhoI. Restriction fragments were separated in 1.0% agarose 
gel, transferred to Hybond N+ membrane (GE Healthcare Lifesciences) and hybridized 
with alkaline phosphatase-labelled mouse mtDNA probes. Probe-bound alkaline 
phosphatase was used to catalyse light production by enzymatic decomposition of CDP-
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Star Detection Reagent (GE Healthcare Lifesciences). Chemiluminescences of fragments 
were measured with a bioimaging analyser, EZ-Capture ST (ATTO). 
Lactate and Glucose Measurement  
To determine blood lactate and glucose concentrations, blood was collected from 
the tail veins of mice. Lactate and glucose concentrations were measured with an 
automatic blood lactate test meter (Lactate Pro; Arkray) and glucose test meter (Dexter 
ZII; Bayer), respectively. 
Micro-computed tomography analysis 
The µ-CT (Scan X mate E090S scanner; Comscantechno) was used to take 
tomography images at three parts in mouse tibia bones. The µ-CT was operated at a tube 
voltage peak of 90 kV and a tube current of 90 mA. Samples were rotated 360° in steps 
of 0.6°, generating 600 projection images of 992 × 992 pixels. The µ-CT data were 
reconstructed at an isotropic resolution of 22.4×22.4×22.4 mm3 (the wide part of tibia) 
and 7×7×7 mm3 (the proximal metaphysis and the mid-diaphysis). 0.1mm brass filter was 
used for the scanning of the wide part of tibia and the mid-diaphysis. For each analysis, 
the region of interest (ROI) was defined on the basis of an anatomical feature.  
Morphometric indices were calculated using TRI/3D-BON (RATOC System 
Engineering) software. Bone mineral density of tibia bones were measured using TRI/3D-
BON-BMD (RATOC Systems) software. 
Ex vivo differentiation of osteoclasts and osteoblasts 
Bone marrow macrophages were induced by incubating bone marrow flushed 
from mouse femurs and tibiae with macrophage inducing medium: MEMalpha Glutamax 
(Gibco) containing 10% fetal bovine serum (FBS) and 10 ng/mL recombinant 
macrophage colony stimulating factor 1 (M-CSF) (Wako), and purified by Ficoll-
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Hypaque (GE Healthcare) gradient centrifugation. Osteoclasts were induced by 
incubating bone marrow macrophages in MEMalpha Glutamax containing 10% FBS, 50 
ng/mL recombinant M-CSF, and 100ng/mL recombinant receptor activator of nuclear 
factor kappa-B ligand (RANKL) (Wako) for 5 days. Pre-osteoblasts were selected from 
bone marrow by incubating whole bone marrow cells in RPMI1640 (Nissui) containing 
10% FBS for 7 days. Osteoblasts were induced by incubating pre-osteoblasts in 
RPMI1640 containing Osteoblast-Inducer Reagent (TaKaRa) for 14 days.  
Quantitative RT-PCR 
Total RNA was extracted from mouse quadriceps muscles by using the RNeasy 
fibrous mini kit (Qiagen). RNA samples were reverse transcribed by using QuantiTect 
Reverse Transcription Kit (Qiagen). Real-time monitoring PCR was performed with 
QuantiTect SYBR Green PCR Kit (Qiagen), an ABI PRISM 7900HT sequence detection 
system (Applied Biosystems), and primers for atrogin-1 (forward, ctctgtaccatgccgttcct; 
reverse, ggctgctgaacagattctcc)  and TATA-box binding protein (forward, 
ggcggtttggctaggttt; reverse, gggttatcttcacacaccatga). The relative expression level of 
atrogin-1 mRNA was calculated by using ΔΔCt method. The gene encoding TATA-box 
binding protein was used as an internal control. The proportion of wild type mtDNA and 
ΔmtDNA was determined by real-time PCR analysis, as described previously [24].  
Histological Analyses  
Frozen sections (10-µm) of quadriceps muscles were hematoxylin and eosin 
(H&E) stained and used to calculation of cross sectional area (CSA). CSA of skeletal 
muscle fibers was calculated by using ImageJ (Rasband, WS., Image J, U.S. National 
Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-2014) 
software. Formalin-fixed, paraffin-embedded serial sections were used for H&E stain to 
identify tumor tissues. The immunohistochemical analysis was performed with antibody 
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to CD45 (BD Biosciences) to determine whether the tumor tissues originated from 
leukocytes, and subsequently with antibodies to B220 (BD Biosciences) and CD3 (Santa 
Cruz) to determine whether the tumor tissues were of B-cell or T-cell origin, respectively. 
Measurement of ROS Production in Mitochondria  
ROS generation was detected with the mitochondrial superoxide indicator 
MitoSOX-Red (Life Technologies). Cells were incubated with 1µM MitoSOX-Red for 
15 min at 37 ºC in phosphate-buffered saline (PBS), washed twice with PBS, and then 
immediately analyzed with a FACScan flow cytometer (Becton Dickinson). 
Statistical Analysis  
Data were analyzed by two-sided Student’s t-test. Kaplan–Meier curves were 
assessed with the log-rank test. P values of less than 0.05 were considered significant. 
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RESULTS 
Mitochondrial Respiration Defects in mtDNA Mutator Mice with a B6J Nuclear 
Background 
I generated heterozygous (+/m) and homozygous (m/m) mtDNA mutator mice 
with a B6J nuclear background (see Materials and Methods), and examined whether 
mtDNA mutator mice with a B6J nuclear background also express respiration defects. 
Young (10-month-old) mice were used for examination of their mitochondrial respiratory 
function. Age-matched normal B6J mice and mito-miceΔ with a B6J nuclear background 
were used as positive and negative controls, respectively. Histochemical analysis of 
mitochondrial cytochrome c oxidase (COX) activity in mouse tissues showed reduced 
COX activity in homozygous m/m mutator mice and mito-miceΔ, and mild COX defects 
in heterozygous +/m mutator mice (Fig. 1A).  
For quantitative estimation of overall mitochondrial respiratory function, I 
isolated immortalized 3T3 cell lines from mouse embryonic fibroblasts (MEFs) by using 
the 3T3 protocol [18, 19; see Methods]. Immortalized 3T3 cell lines obtained from m/m 
mutator mice (3T3m/m) and mito-miceΔ (3T3Δ) showed a similar reduction in both COX 
activity (Fig. 1A) and O2 consumption rates compared to controls (Fig. 1B). Thus, m/m 
mutator mice express notable respiration defects, even when they share B6J nuclear 
genetic background with that of mito-miceΔ.  
Cotransfer of mtDNA and Respiration Defects from m/m Mice into ρ0 Mouse B82 
Cells 
I then addressed whether respiration defects found in mtDNA mutator mice (Fig. 
1) are caused by abnormalities accumulated in mtDNA or in nuclear DNA. It is possible 
that the genetic complementation activity present in mammalian mitochondria [10, 17, 
18] prevents tissues from expressing respiration defects caused by the accumulated 
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random mutations in mtDNA. Moreover, considering that respiratory functions are 
controlled by both mtDNA and nuclear DNA, it is still possible that abnormalities in 
nuclear DNA are responsible for respiration defects, even though mtDNA mutator mice 
are prone to accumulate various somatic mutations in mtDNA [6, 7, 23, 25]. 
To examine this possibility, I transferred mitochondria from the platelets of +/m 
and m/m mutator mice (10 months old) into ρ0 mouse B82 cells by their fusion with the 
platelets. Selection medium without uridine and pyruvate excluded the unfused ρ0 mouse 
B82 cells, and allowed exclusive growth of B82mt+/m and B82mtm/m 
transmitochondrial cybrids, which share the B82 nuclear background but carry mtDNA 
from +/m and m/m mice, respectively (Table 1). As positive controls, I used B82mtWT 
transmitochondrial cybrids, which were obtained by the fusion of ρ0 mouse B82 cells 
with the platelets from age-matched wild-type (WT) B6J mice (Table 1). 
All isolated transmitochondrial cybrids were cultivated for 2 months to obtain a 
sufficient number of cells to estimate O2 consumption rates. COX activity (Fig. 2A) and 
O2 consumption rates (Fig. 2B) were reduced significantly in B82mtm/m cybrids 
compared to controls. These results suggest that mitochondrial respiration defects were 
co-transferred with the mtDNA from m/m mice into ρ0 mouse B82 cells, providing 
convincing evidence that respiration defects expressed in mtDNA mutator mice are due 
to mtDNA abnormalities created by the deficient proofreading function of mtDNA 
polymerase. Moreover, these observations also suggest that the transferred respiration 
defects were not restored during the prolonged 2-month long cultivation of B82mtm/m 
cybrids, even under conditions where the nuclear genome of the cybrids was derived from 
B82 cells possessing mtDNA polymerase with a normal proofreading function. Therefore, 
mtDNA abnormalities are furthermore transferable to following generations of the 
cybrids, and would correspond to mtDNA mutations. 
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Sequence and Southern Blot Analyses of mtDNA from m/m Mice 
To examine whether the mtDNA abnormalities correspond to point mutations or 
deletion mutations of mtDNA, I carried out sequence analysis (Fig. 3A) and Southern 
blot analysis (Fig. 3B) of mtDNA prepared from the heart of an m/m mouse (10 months 
old) and B82mtm/m cybrids. The heart of an age-matched B6J (wild-type) mouse and 
B82mtWT cybrids were used as controls. 
Sequence analysis of fifty clones of a part of COX1 gene revealed that significant 
amounts of point mutations are accumulated in mtDNA from the heart of an m/m mutator 
mouse, while no mutations were found in the heart of an age-matched B6J mouse (Fig. 
3A). Preferential accumulation of somatic point mutations in mtDNA was also observed 
in B82mtm/m cybrids, when I compared mtDNA sequence between B82mtm/m and 
B82mtWT cybrids (Fig. 3A). Therefore, enhanced accumulation of the mtDNA point 
mutations would partly be responsible for the respiration defects found in tissues of m/m 
mutator mice (Fig. 1) and in B82mtm/m cybrids (Fig. 2). 
Southern blot analysis also showed that the heart of an m/m mouse possessed 
deleted mtDNA fragments (about 8kbp) as well as mtDNA with normal sizes (about 
16kbp). However, B82mtm/m cybrids did not possess detectable amounts of the deleted 
mtDNA fragments (Fig. 3B). These observations suggest that the deleted mtDNA 
produced in the tissues of the m/m mouse can partly be responsible for the respiration 
defects (Fig. 1), but are not able to replicate and confer respiration defects in B82mtm/m 
cybrids (Fig. 2). Thus, the deleted products would correspond to the linear mtDNA 
fragments newly created by the mutated polymerase gamma of m/m mice [26], but not to 
mtDNA with deletion mutations. 
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Lifespan and Premature Aging Phenotypes  
Next, I investigated whether homozygous m/m mutator mice carrying a B6J 
nuclear background also express premature aging phenotypes. To examine this idea I 
started the experiments using 6-month-old mice: 19 wild-type B6J mice, 71 mtDNA 
mutator mice (39 +/m and 32 m/m), and 25 mito-miceΔ2.0-60.8 with 2.0-60.8 % ΔmtDNA 
in their tails at 4 weeks after the birth.  
Median survival times of wild-type, +/m, and m/m mutator mice were 26, 27, 
and 10 months, respectively (Fig. 4A), showing that homozygous m/m mutator mice have 
a much shorter lifespan than controls, even under a B6J nuclear background. Median 
survival times of 10 months for m/m mutator mice with a B6J nuclear background is 
slightly shorter than the 11 months [6] and 14 months [7] of other m/m mutator mice 
(Table 2), probably due to the differences in nuclear background and/or conditions for 
feeding and maintenance.  
When the proportions of ΔmtDNA in tails were restricted to higher levels 
(40.0%-60.8%), 13 mito-miceΔ40.0-60.8 possessing 40.0%-60.8% ΔmtDNA in their tails 
had a very short lifespan (9 months; Fig. 4A) comparable to that of m/m mutator mice 
(10 months; Fig. 4A). Thus, damages of mtDNA would be very similar between m/m 
mice and mito-miceΔ40.0-60.8. Moreover, all 13 mito-miceΔ40.0-60.8 showed kyphosis (Fig. 
4B), which has been observed in m/m mutator mice [6, 7] and confirmed in this study to 
be expressed in m/m mutator mice with a B6J nuclear background (Figs. 4B and Table 
2). However, alopecia, which has been reported in m/m mutator mice as a typical 
premature aging phenotype [6, 7], was not observed in m/m mutator mice and mito-
miceΔ40.0-60.8 sharing the same B6J nuclear background (Fig. 4B). The absence of alopecia 
in both m/m mutator mice and mito-miceΔ40.0-60.8 sharing the same B6J nuclear 
background suggest that the apparent discrepancy in the expression of premature aging 
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phenotypes that were observed exclusively in mtDNA mutator mice [6, 7], but not in 
mito-mice [9, 10] might partly be related to slight differences in their nuclear genetic 
background (Table 2). 
Moreover, both the homozygous m/m mutator mice with a B6J nuclear 
background and mito-miceΔ40.0-60.8 had low blood glucose and high blood lactate levels, 
while heterozygous +/m mutator mice were normal in their levels (Fig.4C). These results 
are consistent with the findings of previous studies [9, 27, 28] with the exception that 
m/m mutator mice with a B6J nuclear background have low blood glucose levels (Fig. 
4C). These observations suggest that homozygous m/m mutator mice have potential as a 
model for the study of mitochondrial diseases as well as of aging. However, m/m mutator 
mice and mito-miceΔ40.0-60.8 sharing the B6J nuclear background also showed different 
phenotypes associated with diseases. For example, m/m mutator mice expressed 
significant increase in the amounts of blood lactate levels (Fig. 4C). On the contrary, 
mito-miceΔ exclusively had enlarged kidneys with a granulated surface with renal 
failures [10]. Considering that mito-miceΔ accumulated the same ΔmtDNA with age, and 
that m/m mutator mice accumulated mtDNA with various somatic mutations with age, 
the difference of mutations in mtDNA may partly be responsible for the difference of 
their phenotypes. 
Precise Investigation of Musculoskeletal Phenotypes 
I then addressed the issue that whether mtDNA mutator mice correspond to a 
model of aging or mitochondrial diseases by using aged mice and mito-miceΔ as positive 
controls for aging and mitochondrial diseases, respectively, and investigated precisely 
musculoskeletal disorders, including osteoporosis and muscle atrophy, which have been 
reported in elderly human subjects [19] and mtDNA mutator mice [6, 7]. 
First I compared bone mineral density (BMD) in aged mice, mtDNA mutator 
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mice, and mito-miceΔ, because decreased BMD is an osteoporosis phenotype prevalent 
in elderly human subjects and a phenotype observed in mtDNA mutator mice. I carried 
out quantitative estimation of BMD in tibia bones, and showed that its expression was 
significantly decreased in aged mice, mtDNA mutator mice, and mito-miceΔ compared 
with young mice (Fig. 5A).  
For further investigation of the structural abnormalities associated with the 
decreased BMD (Fig. 5B), I performed X-ray micro-computed tomography (µ-CT) 
analysis of trabecular and cortical bones. Quantitative estimation of trabecular bone 
volume (Fig. 5C) and cortical bone thickness (Fig. 5D) showed that cortical bone 
thickness, but not trabecular bone volume, decreased in both mtDNA mutator mice and 
mito-miceΔ; in contrast, aged mice did not show a significant decrease in either trabecular 
bone volume or cortical bone thickness. Together with the finding that elderly human 
subjects exhibit a decrease in trabecular bone volume but not cortical bone thickness  
[29], these result suggests that decreased cortical bone thickness exclusively found in 
mtDNA mutator mice and mito-miceΔ is not associated with either mouse or human aging. 
I then compared respiratory function by using osteoclasts and osteoblasts, which 
play an important role in bone metabolism. Cytochemical analysis of mitochondrial COX 
activity showed reduced activity in the cells of mtDNA mutator mice and mito-miceΔ, 
but not in the cells of aged mice, when compared with young mice (Fig. 5E). These results 
indicate that the decreased BMD (Fig. 5A) and cortical bone thickness (Fig. 5D) observed 
in mtDNA mutator mice and mito-miceΔ are likely due to respiration defects, whereas 
the decreased BMD observed in aged mice (Fig. 5A) occurred in the absence of the 
respiration defects (Fig. 5E). 
Next, I investigated muscle atrophy, another typical aging phenotype of 
musculoskeletal disorders, which is observed not only in elderly human subjects [19] and 
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mtDNA mutator mice [6, 7], but also in patients with mitochondrial diseases [30], 
cachexia, or sepsis [31]. By isolating and measuring the weight of quadriceps muscles 
(Fig. 6A and B), I observed muscle atrophy in aged mice, mtDNA mutator mice, and 
mito-miceΔ compared with young mice. Furthermore, histochemical analysis also 
showed atrophy of each muscle fiber (Fig. 6C and D), which confirmed the presence of 
muscle atrophy in the quadriceps of all three mouse models.  
Comparison of the mitochondrial respiratory function of quadriceps was 
performed by histochemical analysis of COX activity. Decreased COX activity relative 
to that in young mice was observed in muscle fibers of mtDNA mutator mice and mito-
miceΔ, but not in aged mice (Fig. 6E). Therefore, mitochondrial respiration defects could 
be responsible for the muscle atrophy expressed in mtDNA mutator mice and mito-miceΔ, 
whereas aged mice had muscle atrophy in the absence of the respiration defects. 
Decreased COX activity in muscle fibers corresponds to mitochondrial myopathy, which 
is one of the typical abnormalities frequently observed in patients with mitochondrial 
diseases [1, 2]. Therefore, mtDNA mutator mice and mito-miceΔ also share a phenotype 
associated with mitochondrial diseases.  
For further investigation of muscle atrophy, I examined atrogin-1 mRNA levels, 
because overexpression of the atrogin-1 gene, which encodes an E3 ubiquitin ligase 
involved in proteolysis, is observed in human muscle atrophy caused by cachexia, sepsis, 
or immobilization [31], but not in age-associated muscle atrophy (sarcopenia) developed 
in the elderly [32]. Here I observed that atrogin-1 mRNA was overexpressed in quadriceps 
of both mtDNA mutator mice and mito-miceΔ, but not in aged mice, relative to the levels 
in young mice (Fig. 6F). These observations suggest that the mechanisms behind muscle 
atrophy in mtDNA mutator mice are similar to those in mito-miceΔ, but differ from those 
in aged mice and elderly human subjects, that develop muscle atrophy in the absence of 
atrogin-1 overexpression. 
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Tumor Formation Frequencies of +/m Mice  
Although heterozygous +/m mutator mice showed mild respiration defects (Fig. 
1), they had a normal lifespan (Fig. 4A) that was comparable to a lifespan of wild-type 
mice. These results are consistent with the findings of a previous study [33] that showed 
that median survival times of +/m mice did not change substantially from those of wild-
type mice. However, gross necropsy of all dead or euthanized moribund mice revealed 
that 15 of 29 +/m mutator mice (52%) had macroscopic tumor-like abnormalities in 
spleen, liver and/or lymph nodes (Table 3 and Fig. 7A). By comparison, only 2 of 12 
wild-type mice (17%) and none of the 32 m/m mutator mice showed tumor-like 
abnormalities (Table 3). 
Histological analyses revealed that all abnormal tissues were hematopoietic 
neoplasms and were positive for the pan-leukocyte marker CD45 (Table 3 and Fig. 7B). 
Since there was no increase in the number of leukemic cells in the peripheral blood of 
+/m mice compared with wild-type mice (Fig. 7A), these hematological neoplasms most 
likely consisted of lymphoma cells. All tumors were of B-cell origin because they 
expressed the B-cell marker B220 (Fig. 7B), and arose in the spleen, liver, lung, and/or 
lymph nodes (Table 3 and Fig. 7A). These data indicated that compared to wild-type mice, 
the +/m mutator mice were more prone to B-cell lymphoma development.  
The median survival times of +/m mutator mice with and without B-cell 
lymphoma were 26 and 28 months, respectively (Fig. 7C). The shorter lifespan of +/m 
mutator mice with B-cell lymphoma compared with that of +/m mutator mice without B-
cell lymphoma is most likely partly the result of B-cell lymphoma development. 
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Estimation of ROS in Bone Marrows of +/m Mice with and without B-cell 
Lymphomas 
Previous report showed that aged mito-miceND6M carrying an mtDNA point 
mutation G13997A in the ND6 gene frequently developed B cell-lymphomas [14]. 
Because bone marrow cells of mito-miceND6M overproduce ROS [14], the 
overproduction of ROS in bone marrow cells of +/m mutator mice might be crucial for 
the development of B-cell lymphoma (Table 3). To examine this idea, I compared the 
amount of mitochondrial ROS in the bone marrow cells of wild-type mice with that of 
+/m mutator mice (20-25 months old). An increase in the amount of mitochondrial ROS 
was observed only in +/m mutator mice with B-cell lymphomas (Fig. 8). It is therefore 
likely that the overproduction of ROS in bone marrow cells of +/m mutator mice plays 
an important part in the formation of B-cell lymphoma. 
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DISCUSSION 
By generating mtDNA mutator mice with the same B6J nuclear background as 
that of mito-miceΔ, I can provide an answer to the question of why premature aging 
phenotypes are exclusively observed in homozygous m/m mutator mice but not in 
transmitochondrial mito-miceΔ, even though they both express significant respiration 
defects. I showed that the significant respiration defects and high frequency of mtDNA 
mutations were expressed in m/m mutator mice generated here, and can be transferred 
together with the transfer of mtDNA from the platelets of the m/m mutator mice into ρ0 
B82 cells (Figs. 1-3). Thus, mutator mice also express respiration defects, even under a 
B6J nuclear background, and respiration defects found in mutator mice are caused by 
abnormalities in their mtDNA. However, the m/m mutator mice with a B6J nuclear 
background did not express the premature aging phenotypes of graying and alopecia, 
while they did express kyphosis and had a short lifespan (Fig. 4). Similar phenotypes 
were observed in mito-miceΔ40.0-60.8, when the proportions of ΔmtDNA were restricted to 
higher levels (Fig. 4). Therefore, the expression patterns of premature aging phenotypes 
of m/m mutator mice with a B6J nuclear background are very similar to that of mito-
miceΔ carrying predominant amounts of ΔmtDNA in that they both express kyphosis and 
have a short lifespan, but do not express graying and alopecia. These observations suggest 
that the apparent discrepancy in the presence and absence of premature aging phenotypes 
in mutator mice and mito-mice from previous studies is partly the result of differences in 
their nuclear genetic background. 
The mitochondrial theory of aging [1-5] proposes a vicious cycle of age-
associated accumulation of somatic mutations in mtDNA and the resultant respiration 
defects and overproduction of ROS. This concept was partly supported by studies in 
mtDNA mutator mice, which had premature aging phenotypes along with the 
accumulation of somatic mutations in mtDNA, although they did not display ROS 
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overproduction [7, 8]. However, mito-miceΔ showing age-associated accumulation of the 
mutated mtDNA and the resultant respiration defects had no premature aging phenotypes 
[9, 10]. I addressed to the controversial issue that mtDNA mutator mice, but not mito-
miceΔ, express premature aging phenotypes, and revealed that decreased cortical bone 
thickness (Fig. 5D) and overexpression of atrogin-1 in muscle atrophy (Fig. 2F) were 
exclusively observed in mtDNA mutator mice and mito-miceΔ, but not in aged mice.  
Therefore, the spectra of musculoskeletal disorders in mtDNA mutator mice and 
mito-miceΔ are similar to each other, but different from those in aged mice. Considering 
that the spectra of musculoskeletal disorders in mtDNA mutator mice and mito-miceΔ are 
also different from those in elderly human subjects [29, 32], they would not be associated 
with either mouse or human aging. Then, a question that arises is whether decreased 
cortical bone thickness and increased atrogin-1 mRNA expression in muscle fibers are 
associated with mitochondrial diseases. To answer this question, further works are 
required to investigate whether the patients with mitochondrial diseases express these 
abnormalities.  
Heterozygous +/m mutator mice showed only slight respiration defects (Figs. 1 
and 2) and had a normal lifespan comparable to that of wild-type mice (Fig. 4A), which 
are findings consistent with a previous publication [33]. However, this study provided the 
new evidence that +/m mutator mice with a B6J nuclear background frequently develop 
age-associated B-cell lymphomas. The +/m mutator mice developed no tumors other than 
B-cell lymphomas (Table 3), despite the presence of mtDNA abnormalities in all the 
tissues. Considering that 17% of the wild-type mice formed B-cell lymphoma but no other 
tumors (Table 3), one answer to this tissue-specific tumor development in +/m mice is 
that the nuclear background of the B6J mice used in this study made them prone to the 
development of B-cell lymphomas. In support of this notion, it has been reported that the 
nuclear genetic background affects the spectrum of tumors that develop in mice [34-37].  
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With respect to the mechanism underlying the development of B-cell lymphoma 
in +/m mice, the overproduction of ROS in bone marrow cells may be related, because 
oxidative stress induces various types of cellular damages that can lead to genetic 
instability and subsequent tumor development [38]. However, it has been reported that 
tissues and cells from mtDNA mutator mice do not overproduce ROS [7, 8, 39]. This 
study also showed that bone marrow cells in +/m mice do not overproduce mitochondrial 
ROS (Fig. 6). In contrast, bone marrow cells from +/m mice carrying B-cell lymphomas 
exclusively overproduced mitochondrial ROS (Fig. 6). It is therefore possible that a 
population of bone marrow cells was induced to overproduce ROS as the results of B-cell 
lymphoma development. It is also possible that a small population of bone marrow cells 
accumulates specific mtDNA abnormalities that, by chance, induce ROS overproduction 
resulting in the development of B-cell lymphoma. The latter idea is supported by recent 
findings that B-cell lymphomas developed preferentially in transmitochondrial mito-
miceND6M carrying a ROS-inducing mtDNA mutation [14] but did not in 
transmitochondrial mito-miceCOIM carrying an mtDNA point mutation that does not 
induce ROS overproduction [14]. Taken together, these observations suggest that mtDNA 
abnormalities in +/m mice do not accelerate aging (Fig. 4A), but preferentially induce B-
cell lymphoma development (Table 3).  
Because previous studies [10, 17, 18] demonstrated the presence of inter-
mitochondrial interactions and the resultant genetic complementation that occurs in 
mammalian mitochondria, it is possible that accumulated random mutations in mtDNA 
complemented each other and fail to induce the respiration defects found in mtDNA 
mutator mice. However, this study provided convincing evidence that respiration defects 
can be transferred together with mtDNA from mtDNA mutator mice into ρ0 mouse B82 
cells (Fig. 2). These findings suggest that respiration defects in mtDNA mutator mice (Fig. 
1) are caused by abnormalities in their mtDNA. One explanation of why random 
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mutations in the mtDNA of mtDNA mutator mice induce respiration defects in the 
presence of mitochondrial genetic complementation is that the extremely high frequency 
of somatic mutations in mtDNA causes instability of the large mitochondrial respiration 
complexes thereby resulting in respiration defects, even when somatic mutations occur at 
random sites [25]. This idea could be examined by complete sequence analysis of mtDNA 
in tissues of m/m mice. 
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TABLES 
Table 1  
Isolation of the trans-mitochondrial cybrids 
    Fusion combination     
Cells   Nucleara donors  X  mtDNA donors   Selection 
Nuclear donors=mtDNA 
recipients 
    
0 B82 cellsa     
mtDNA donors     
platelets (WT mice)     
platelets (+/m mice)     
platelets (m/m mice)     
Cybrids     
B82mtWT  0 B82 cells  X  platelets (WT mice)  UP-b 
B82mt+/m   0 B82 cells  X  platelets (+/m mice)  UP- 
B82mtm/m    0 B82 cells  X  platelets (m/m mice)   UP- 
aB82 cells are fibrosarcomas derived from the L929 fibroblast cell line (C3H/An 
mouse strain), and 0 B82 cells without their own mtDNA were isolated in 
previous report (9).  
bUP- represent the selection medium without uridine and pyruvate to exclude 
unfused  0 B82 cells. 
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Table 2 
Characterization of the mice used in the previous studies and this study 
  m/m mutator 
mice  (Ref. 6) 
m/m mutator 
mice (Ref. 7) 
m/m mutator 
mice (this study) 
mito-miceΔ40.0-60.8  
(this study)  
Strain 129;B6 B6 B6Ja B6Ja 
 Lifespan 
(months) 
11 14 10 9 
Kyphosis + + + + 
Hair graying 
Not 
detectableb 
+ - - 
Alopeciac + + - - 
a A B6J strain used in this study corresponds to a B6JJcl strain generated by 
sibling mating more than 40 times in CLEA Japan (Jcl). 
b Expression of a hair graying phenotype is not detectable in this strain because 
of its phenotypic expression of  white hair color [6]. 
c Alopecia was observed in m/m mice with B6 strain nuclear genome [7] and in 
m/m mice with 129R1/B6 strain nuclear genome [6], but not in m/m mice with 
B6JJcl nuclear genome generated in this study. Since nuclear genomes are very 
close between B6 strain used in the previous study [7] and B6JJcl strain used in 
this study, variability of nuclear genome may not be responsible for the lack of 
alopecia in m/m mice with B6JJcl strain nuclear genome. On the contrary, this 
study also showed that m/m mice as well as mito-mice sharing the same B6JJcl 
nuclear genetic background and feeding conditions did not express alopecia (Fig. 
4), suggesting that slight variability of nuclear genome between B6 and B6JJcl 
mice and/or different conditions for feeding and maintenance may due at least in 
part to the discrepancy that the alopecia was not observed in m/m mice of this 
study. 
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Table 3 
Frequencies of lymphoma in dead or moribund mice 
    
No. of mice with 
lymphoma 
(Individual code a) 
  Tissues with tumor   Histological analyses   
mice 
Total 
no. of 
mice 
Life span 
(months) 
Spleen Liver Lung 
Lymph 
node 
  HE CD45 B220 CD3 
Cell 
lineage 
+/+ 12 2            
  (5) 25 +   +  Lymphoma + + - B cell 
  (8) 24 +   +  Lymphoma + + - B cell 
+/m 29 15            
  (1) 29 +   +  Lymphoma + + - B cell 
  (2) 30 +     Lymphoma + + - B cell 
  (3) 25 + +  +  Lymphoma + + - B cell 
  (4) 28 + +  +  Lymphoma + + - B cell 
  (5) 28 + +  +  Lymphoma + + - B cell 
  (6) 25 +   +  Lymphoma + + - B cell 
  (8) 26 + +  +  Lymphoma + + - B cell 
  (10) 24 + +  +  Lymphoma + + - B cell 
  (11) 25 + +  +  Lymphoma + + - B cell 
  (12) 29 + +  +  Lymphoma + + - B cell 
  (13) 25 + + +   Lymphoma + + - B cell 
  (23) 22 + +  +  Lymphoma + + - B cell 
  (24) 22 +   +  Lymphoma + + - B cell 
  (25) 33 +  +   Lymphoma + + - B cell 
  (29) 26 +   +  Lymphoma + + - B cell 
m/m 32 0                       
a Individual codes were allocated in order of death. 
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FIGURES 
Figure 1 
Comparison of mitochondrial respiratory function in mtDNA mutator mice and 
mito-miceΔ.  
WT, wild-type mice; +/m, heterozygous mutator mice; m/m, homozygous mutator 
mice; Δ, mito-miceΔ.  
(A) Histochemical analysis of mitochondrial respiratory enzyme activities in the 
heart, kidney, and 3T3 cells. Tissue sections and 3T3 cells were stained for 
cytochrome c oxidase (COX) (brown) and succinate dehydrogenase (SDH) (blue). 
Cells that had lost COX activity were detected as a blue colour. The proportions 
of ΔmtDNA in the heart, kidney tissues, and 3T3 cells from mito-miceΔ were 
82.6%, 79.1%, and 73.8%, respectively. A scale bar, 50 µm.  
(B) Measurement of O2 consumption rates in 3T3 cells. Data are represented as 
mean values with SD (n = 3). *P < 0.05 compared with wild-type mice. 
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Figure 2 
Cotransfer of mtDNA and respiration defects from mtDNA mutator mice into ρ0 
mouse B82 cells.  
WT, wild-type mice; +/m, heterozygous mutator mice; m/m, homozygous mutator 
mice.  
(A) Cytochemical analysis of mitochondrial respiratory enzyme activities in trans-
mitochondrial cybrids. Cells that had lost COX activity were detected as a blue 
colour. A scale bar, 50 µm.  
(B) Measurement of O2 consumption rates. Data are represented as mean values 
with SD (n = 3). *P < 0.05 compared with wild-type mice. 
  
35 
 
 
  
36 
 
Figure 3 
Sequence and Southern blot analyses of mtDNA from mtDNA mutator mice.  
Total DNA was prepared from the hearts of a 10-month-old wild-type mouse (WT) 
and an age matched homozygous mutator mouse (m/m), and from the trans-
mitochondrial cybrids carrying mtDNA from platelets of a 10-month-old wild-type 
mouse and age-matched m/m mutator mouse, respectively.  
(A) Sequence analysis of 517 bp-fragments of the COX1 gene. Numbers of 
somatic mutations in mtDNA of the hearts from a wild-type mouse and an m/m 
mouse, and of the cybrids with mtDNA of a wild-type and an m/m mouse were 
counted.  
(B) Southern blot analysis of XhoI-digested mtDNA. Lanes 1 and 2 represent the 
hearts of a WT and an m/m mouse, respectively. Lanes 3 and 4 represent the 
cybrids with mtDNA of a wild-type and an m/m mouse, respectively. 
  
37 
 
 
  
38 
 
Figure 4 
Comparison of the phenotypes observed in mtDNA mutator mice and mito-miceΔ.  
(A) Kaplan–Meier survival curves of mtDNA mutator mice and mito-miceΔ. 
Median survival times of wild-type (WT) mice (n = 19), +/m mice (n = 39), m/m 
mice (n = 32), mito-miceΔ2.0-40.0 (n = 12), and mito-miceΔ40.0-60.8 (n = 13) were 26, 
27, 10, 17, and 9 months, respectively.  
(B) WT mouse, m/m mouse, and mito-mouseΔ at 9 months of age. Kyphosis was 
observed in homozygous m/m mutator mice and mito-miceΔ, while hair graying 
and hair loss (alopecia) were not observed.  
(C) Estimation of blood glucose and blood lactate levels in mutator mice and mito-
miceΔ40-60.8 at 9 months of age. WT, wild-type mice; +/m, heterozygous mutator 
mice; m/m, homozygous mutator mice; Δ, mito-miceΔ. Data are represented as 
mean values with SD (n = 3). *P < 0.05 compared with wild-type mice. 
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Figure 5 
Characterization of phenotypes of osteoporosis displayed in tibia bones of 
mtDNA mutator mice. Aged mice and mito-miceΔ were used as controls 
expressing phenotypes associated with aging and mitochondrial diseases, 
respectively. All mice were males sharing the B6J nuclear genetic background. 
Young, 10-month-old mice; Aged, 27-month-old mice; Mutator, 10-month-old 
mtDNA mutator mice; Delta, 10-month-old mito-mice Δ . The proportions of 
ΔmtDNA in the tail from mito-miceΔ were 57.5 ± 2.5 % at 4 weeks after birth and 
81.2 ± 1.3 % at 10 months old. 
(A) Quantitative estimation of BMD. Data are means ± SD. *, P < 0.05 (n = 3).  
(B) µ-CT analysis of trabecular and cortical bones. Upper panel, red-colored 
areas correspond to trabecular bones; lower panel, bone areas exclusively 
consisting of cortical bones (gray-colored areas). Scale bar, 500 µm.  
(C) Quantitative estimation of the ratio of trabecular bone volume/ tissue volume 
(BV/TV). Data are means ± SD. *, P < 0.05 (n = 3).  
(D) Quantitative estimation of cortical bone thickness (Ct). Data are means ± SD. 
*, P < 0.05 (n = 3).  
(E) Cytochemical analysis of COX activity. OCs, osteoclasts; OBs, osteoblasts. 
Cells that had lost their COX activity were detected as a blue color. The 
proportions of ΔmtDNA in the bone marrow cells, osteoclasts, and osteoblasts 
were 65.1 %, 61.5 %, and 57.7 %, respectively. Scale bars, 50 µm. 
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Figure 6 
Characterization of phenotypes of muscle atrophy displayed in quadriceps of 
mtDNA mutator mice. Aged mice and mito-miceΔ were used as controls of 
phenotypes associated with aging and mitochondrial disease, respectively. All 
mice were males sharing the B6J nuclear genetic background. Young, 10-month-
old mice; Aged, 27-month-old mice; Mutator, 10-month-old mtDNA mutator mice; 
Delta, 10-month-old mito-miceΔ.  
(A) Images of whole quadriceps. The proportions of ΔmtDNA in the quadriceps 
from mito-miceΔ were 82.6 %. Scale bar, 5 mm. 
(B) Tissue weights of quadriceps. The proportions of ΔmtDNA in the quadriceps 
muscles from mito-miceΔ were 83.1 ± 2.2 %. Data are means ± SD. *, P < 0.05 
(n = 3).  
(C) Hematoxylin and eosin (H&E) staining of muscle fibers in quadriceps. The 
proportions of ΔmtDNA in the quadriceps from mito-miceΔ were 83.2 %. Scale 
bar, 50 µm.  
(D) Quantitative estimation of cross-sectional areas (CSA) of each muscle fiber. 
The proportions of ΔmtDNA in the quadriceps muscles from mito-miceΔ were 
82.9 ± 2.1 %. Data are means ± SD. *, P < 0.05.  
(E) Histochemical analysis of COX activity in quadriceps. The intensity of brown-
staining represents the level of COX activity. The proportions of ΔmtDNA in the 
quadriceps from mito-miceΔ were 82.7 %. Scale bar, 50 µm.  
(F) Estimation of the mRNA levels of atrogin-1 in quadriceps by using quantitative 
real-time PCR. The proportions of ΔmtDNA in the quadriceps muscles from mito-
miceΔ were 83.0 ± 1.8 %. Data are means ± SD. *, P < 0.05 (n = 4). 
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Figure 7 
B-cell lymphoma formation in the tissues of aged +/m mutator mice. WT, wild-
type mice; +/m, heterozygous mutator mice.  
(A) Gross necropsy of euthanized moribund mice (upper panels), tissues (middle 
panels), and smear samples of peripheral blood stained with Giemsa (lower 
panels). Left and right panels represent a euthanized moribund wild-type (WT) 
mouse without tumors and a euthanized moribund +/m mouse with tumors (+/m 
mouse-4; see Table 2), respectively. Giemsa-stained preparations show the 
absence of leukemic cells in the peripheral blood of both wild-type and +/m mice. 
Sp, spleen; Li, liver; LN, lymph node; PB, peripheral blood. Scale bars represent 
1cm (middle panels) and 50 µm (lower panels). 
(B) Histological analyses of serial sections of the liver to identify B-cell lymphoma. 
Hematoxylin and eosin (HE) staining to show tumor formation; CD45, 
immunohistochemistry using antibody to CD45 to detect leukocytes; B220, 
immunohistochemistry using antibody to B220 to detect B cells; CD3, 
immunohistochemistry using antibody to CD3 to detect T cells. The tissues of WT 
mice have a normal structure (left), whereas those of +/m mice show of the 
development of B-cell lymphoma, because they stained positively with CD45 and 
B220, but not with CD3 (right). A scale bar, 50 μm.  
(C) Kaplan–Meier survival curves of +/m mice with or without lymphoma. Median 
survival times of +/m mice with lymphoma (n = 15) and +/m mice without 
lymphoma (n = 14) were 26 and 28 months, respectively. +, +/m mice with 
lymphoma; −, +/m mice without lymphoma; P = 0.362 
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Figure 8 
Estimation of mitochondrial ROS levels in bone marrow cells of +/m mice with 
and without B-cell lymphoma. WT, wild-type mice; +/m, heterozygous mutator 
mice; −, mice without lymphoma; +, mice with lymphoma.  
Relative mitochondrial superoxide levels in +/m mice without B-cell lymphoma 
and +/m mice with B-cell lymphoma were expressed as mean ﬂuorescence 
intensity after treatment with MitoSOX Red (Life Technologies). Data are 
represented as mean values with SD (n = 5). *P < 0.05 compared with wild-type 
mice. 
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